Kasper Lamberth
Papers
1
Total Citations
91
H-Index
1
About
Kasper Lamberth is a leading immunologist whose research focuses on peptide-MHC interactions and high-throughput screening technologies for T-cell epitope discovery. His major contributions center on developing robust, scalable assays to characterize peptide binding to HLA class I molecules—critical for vaccine design and cancer immunotherapy. His landmark 2009 paper, "Peptide Binding to HLA Class I Molecules: Homogenous, High-Throughput Screening, and Affinity Assays," has garnered 91 citations, establishing a gold-standard methodology for quantifying binding affinities across diverse HLA alleles. This work enabled systematic identification of immunogenic peptides, directly impacting epitope-based vaccine development and neoantigen targeting. Lamberth’s innovations have been instrumental in bridging basic immunology with translational applications, particularly in infectious disease and oncology. His assays remain widely adopted in academic and industrial labs, reflecting their enduring utility. Through this foundational research, Lamberth has shaped how researchers approach HLA-peptide binding characterization, accelerating the discovery of targets for next-generation immunotherapies.
Research Focus
Key Achievements
Top Papers
- 1